Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been ...
WASHIGNTON: Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been pre-ordered around the world.
As research laboratories around the world race to develop a vaccine, manufacturers have received financing to help them prepare to have millions of doses ready to administer in 2021 or even before the end of the year. The United States has allocated funding to more companies than other nation in the hope that one of them will come up with the vaccine to counter the highly contagious virus.
Two vaccine developers - Oxford/AztraZeneca and Sanofi/GSK - have signed or are in advanced negotiations with the European Commission to provide a combined 700 million vaccine doses. Japanese pharmaceutical giant Takeda bought the rights to a Novavax vaccine for Japan, which has funded the research. It would be produced locally.
READ: Alarm among global health experts after Russia's COVID-19 vaccine set to be approved without full trial dataThe Coalition for Epidemic Preparedness Innovations , launched in 2017 by Norway, India, the Bill and Melinda Gates Foundation and the Wellcome Trust, seeks to ensure that there is"equitable access" to future vaccines.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Singapore 'not returning to a pre-Covid-19 world': Chan Chun SingSINGAPORE cannot afford to wait out the coronavirus crisis, as permanent changes mean that there will be no going back to a pre-Covid-19 economy. Read more at The Business Times.
Read more »
Commentary: Why are Melbourne's COVID-19 numbers so stubbornly high?MELBOURNE: Melbourne residents have now been wearing mandatory face coverings in public for two weeks. Yet Premier Daniel Andrews on Tuesday (Aug ...
Read more »
US governors question cost of Trump Covid-19 aid plans, urge talks to continueWASHINGTON (REUTERS) - Republican and Democratic governors said on Monday (Aug 10) President Donald Trump's coronavirus relief measures were too expensive for states to implement as they struggle with the costs of the pandemic, and called on officials in Washington to resume negotiations on federal aid.. Read more at straitstimes.com.
Read more »